SOX Combined With Tislelizumab and LDRT for Neoadjuvant Treatment of Locally Advanced Gastric Cancer
Clinical trial NCT06266871 · UNKNOWN
Trial details
- NCT number
- NCT06266871
- Sponsor
- West China Hospital
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-10
- Primary completion
- 2026-06-30
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.